The Black Health Block Quit & Screen Project

Status Not yet recruiting

Clinical Trial Summary

The Black Health Block Quit and Screen Project seeks to engage Black health care providers in helping Black smokers quit tobacco use, including menthol cigarettes and flavored cigars, and screen for lung cancer early as strategies to reduce multiple chronic disease disparities. The goal of this clinical trial is to test the feasibility and impact of the Black Health Block Culturally Tailored Training alone versus the Health Disparities and Lung Cancer Screening Training + the Black Health Block Culturally Tailored training modules on changes in knowledge, attitudes, and behavioral intentions related to provider advice to quit smoking and referrals for low dose computed tomography among health care providers randomly assigned to each condition. Participants will complete the training modules and complete pre- and post-tests to assess these outcomes.

Clinical Trial Description

This clinical trial tests the feasibility and impact of the Black Health Block Culturally Tailored Training alone versus the Health Disparities and Lung Cancer Screening Training + the Black Health Block Culturally Tailored training modules on changes in knowledge, attitudes, and behavioral intentions related to provider advice to quit smoking and referrals for low dose computed tomography among health care providers randomly assigned to each condition. In partnership with the National Medical Association, investigators will recruit 300 healthcare providers who provide clinical services to Black individuals who smoke smoke. Interested providers will be screened; if eligible, the will complete informed consent. Providers who complete the online consent and agree to enroll in the training study will be individually randomized to one of 2 conditions: The Black Health Block Culturally Tailored + the HDLCS or Black Health Block Culturally Tailored control condition alone. After randomization, providers will complete a pre-test assessing their knowledge, attitudes, and behavioral intentions related to provider advice to quit smoking and referrals for low dose computed tomography. Providers will then complete an online training. Providers will then complete a post-test assessing their 1) knowledge, attitudes, and behavioral intentions related to provider advice to quit smoking and referrals for low dose computed tomography and 2) preferences for the online materials and satisfaction with the training. Feasibility will be assessed using data on provider interest in the training and training reach. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06350643
Study type	Interventional
Source	University of Arkansas
Contact	Mignonne Guy, PhD
Phone	804-828-1731
Email	mguy@vcu.edu
Status	Not yet recruiting
Phase	N/A
Start date	July 2024
Completion date	December 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05114187` - An Internet-Based Education Program for Care Partners of People Living With Dementia	N/A
Recruiting	`NCT03672409` - Diabetes Training Program for Health Professionals From Hermosillo, Sonora	N/A
Completed	`NCT04236024` - The Effects of Board Game in Learning Medication Knowledge Among Nursing Students	N/A
Completed	`NCT03241693` - Blended-learning in Physiotherapy: Professional Ethics	N/A
Not yet recruiting	`NCT06467890` - Knowledge of Vital Pulp Therapy in Permanent Teeth After Educational Programme: A Before and After Study
Completed	`NCT06428474` - Implementation of Oral Health Educational Program on Orphan Children	N/A
Completed	`NCT03002181` - Pain Neurophysiology Education for Sport Therapy Students	N/A
Completed	`NCT01043341` - Knowledge and Attitude About HPV Vaccines	Phase 4
Recruiting	`NCT06231485` - Socialization To Enrich Participation & Support Sexuality for Young People With I/DD	N/A
Completed	`NCT03301714` - Oral Health Education Interventions Among Seniors	N/A
Completed	`NCT04537260` - An Educational Video's Impact on the Induction of Labor Experience	N/A
Completed	`NCT04229654` - Awareness, Expectations, and Perception of Anomaly Scan Among Mexican Pregnant Women
Completed	`NCT02710019` - Good Shepherd: Back to Reality Series	N/A
Recruiting	`NCT05265689` - Study to Improve Adolescent Bicycling Safety	N/A
Completed	`NCT05968872` - Assessing Knowledge & Attitude of Health Professionals Towards Anesthesia and the Anesthetist's Role.
Active, not recruiting	`NCT06320808` - Evaluating FDA's Proposed Patient Medication Information Handout	N/A
Completed	`NCT06388356` - Patient's Informational Privacy in Prehospital Emergency Care - Educational Intervention Study for the Paramedics	N/A
Completed	`NCT05255627` - Mobile Application Effectiveness in Pressure Injury Care	N/A
Completed	`NCT06366607` - Managing High-alert Medication Administration and Errors
Active, not recruiting	`NCT06408090` - Underutilization of Hospice Care in Older Black Adults	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.